About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 379206, 13 pages
http://dx.doi.org/10.1155/2013/379206
Research Article

Therapeutic Time Window for Edaravone Treatment of Traumatic Brain Injury in Mice

1Department of Anatomy, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan
2Department of Emergency and Critical Care Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo 142-8555, Japan

Received 5 January 2013; Revised 8 March 2013; Accepted 11 March 2013

Academic Editor: Norma Possa Marroni

Copyright © 2013 Kazuyuki Miyamoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. W. Brown, E. P. Elovic, S. Kothari, S. R. Flanagan, and C. Kwasnica, “Congenital and acquired brain injury. 1. Epidemiology, pathophysiology, prognostication, innovative treatments, and prevention,” Archives of Physical Medicine and Rehabilitation, vol. 89, no. 3, pp. S3–S8, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. E. M. Manno, A. A. Rabinstein, E. F. M. Wijdicks et al., “A prospective trial of elective extubation in brain injured patients meeting extubation criteria for ventilatory support: A Feasibility Study,” Critical Care, vol. 12, no. 6, article R138, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Rutland-Brown, J. A. Langlois, K. E. Thomas, and Y. L. Xi, “Incidence of traumatic brain injury in the United States, 2003,” Journal of Head Trauma Rehabilitation, vol. 21, no. 6, pp. 544–548, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Zaloshnja, T. Miller, J. A. Langlois, and A. W. Selassie, “Prevalence of long-term disability from traumatic brain injury in the civilian population of the United Statet 2005,” Journal of Head Trauma Rehabilitation, vol. 23, no. 6, pp. 394–400, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Yoshida, H. Yanai, Y. Namiki, K. Fukatsu-Sasaki, N. Furutani, and N. Tada, “Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury,” CNS Drug Reviews, vol. 12, no. 1, pp. 9–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Watanabe, S. Yuki, M. Egawa, and H. Nishi, “Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions,” Journal of Pharmacology and Experimental Therapeutics, vol. 268, no. 3, pp. 1597–1604, 1994. View at Scopus
  7. Y. Inokuchi, S. Imai, Y. Nakajima et al., “Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo,” Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 2, pp. 687–698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. G. H. Wang, Z. L. Jiang, Y. C. Li, et al., “Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats,” Journal of Neurotrauma, vol. 28, pp. 2123–2134, 2011.
  9. E. Otomo, H. Tohgi, K. Kogure et al., “Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: randomized, placebo-controlled, double-blind study at multicenters,” Cerebrovascular Diseases, vol. 15, no. 3, pp. 222–229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Sharma, M. Sinha, R. K. Shukla, R. Garg, R. Verma, and M. K. Singh, “A randomized controlled clinical trial to compare the safety and efficacy of edaravone in acute ischemic stroke,” Annals of Indian Academy of Neurology, vol. 14, no. 2, pp. 103–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Tabrizchi, “Edaravone Mitsubishi-Tokyo,” Current Opinion in Investigational Drugs, vol. 1, no. 3, pp. 347–354, 2000. View at Scopus
  12. S. Ohta, Y. Iwashita, H. Takada, S. Kuno, and T. Nakamura, “Neuroprotection and enhanced recovery with edaravone after acute spinal cord injury in rats,” Spine, vol. 30, no. 10, pp. 1154–1158, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Dohi, K. Satoh, T. Nakamachi et al., “Does edaravone (MCI-186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury?” Antioxidants and Redox Signaling, vol. 9, no. 2, pp. 281–287, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Itoh, T. Satou, S. Nishida et al., “Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats,” Neurochemical Research, vol. 35, no. 2, pp. 348–355, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Munakata, H. Ohkuma, T. Nakano, N. Shimamura, K. Asano, and M. Naraoka, “Effect of a free radical scavenger, edaravone, in the treatment of patients with aneurysmal subarachnoid hemorrhage,” Neurosurgery, vol. 64, no. 3, pp. 423–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Dohi, K. Satoh, Y. Mihara et al., “Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury,” Journal of Neurotrauma, vol. 23, no. 11, pp. 1591–1599, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. E. D. Hall, M. R. Detloff, K. Johnson, and N. C. Kupina, “Peroxynitrite-mediated protein nitration and lipid peroxidation in a mouse model of traumatic brain injury,” Journal of Neurotrauma, vol. 21, no. 1, pp. 9–20, 2004. View at Scopus
  18. A. Lewén, P. Matz, and P. H. Chan, “Free radical pathways in CNS injury,” Journal of Neurotrauma, vol. 17, no. 10, pp. 871–890, 2000. View at Scopus
  19. K. Dohi, H. Ohtaki, T. Nakamachi et al., “Gp91phox (NOX2) in classically activated microglia exacerbates traumatic brain injury,” Journal of Neuroinflammation, vol. 7, no. 41, 2010.
  20. H. Mizushima, C. J. I. Zhou, K. Dohi et al., “Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1,” Journal of Comparative Neurology, vol. 448, no. 2, pp. 203–216, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Ohtaki, A. Takaki, L. Yin et al., “Suppression of oxidative stress after transient focal ischemia in interleukin-1 knock out mice,” Acta Neurochirurgica, no. 86, pp. 191–194, 2003. View at Scopus
  22. D. L. Brody, C. Mac Donald, C. C. Kessens et al., “Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury,” Journal of Neurotrauma, vol. 24, no. 4, pp. 657–673, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. L. C. Schmued and K. J. Hopkins, “Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration,” Brain Research, vol. 874, no. 2, pp. 123–130, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Ohtaki, J. H. Ylostalo, J. E. Foraker et al., “Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 38, pp. 14638–14643, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. Inoue, H. Ohtaki, T. Nakamachi, S. Shioda, and Y. Okada, “Anion channel blockers attenuate delayed neuronal cell death induced by transient forebrain ischemia,” Journal of Neuroscience Research, vol. 85, no. 7, pp. 1427–1435, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Ohtaki, T. Takeda, K. Dohi et al., “Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice,” Neuroscience Research, vol. 58, no. 4, pp. 349–355, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Yamaguchi, M. H. Hussein, G. A. Daoud et al., “Edaravone, a hydroxyl radical Scavenger, ameliorates the severity of pulmonary hypertension in a porcine model of neonatal sepsis,” Tohoku Journal of Experimental Medicine, vol. 223, no. 4, pp. 235–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Koizumi, H. Tanaka, S. Sakaki, and S. Shimazaki, “The therapeutic efficacy of edaravone in extensively burned rats,” Archives of Surgery, vol. 141, no. 10, pp. 992–995, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Sano, T. Motomura, F. Yamamoto, M. Fukuda, T. Mukai, and M. Maeda, “1-(3′-[125I]iodophenyl)-3-methy-2-pyrazolin-5-one: preparation, solution stability, and biodistribution in normal mice,” Chemical and Pharmaceutical Bulletin, vol. 58, no. 8, pp. 1020–1025, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Sonoda, N. Nitta, A. Seko et al., “Edaravone prevents bowel infarction after acute superior mesenteric artery thromboembolism using autologous fibrin clots in a rabbit model,” British Journal of Radiology, vol. 82, no. 981, pp. 711–715, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Vandelle and M. Delledonne, “Peroxynitrite formation and function in plants,” Plant Science, vol. 181, pp. 534–539, 2011.
  32. M. D. Goodman, A. T. Makley, N. L. Huber et al., “Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury,” Journal of Surgical Research, vol. 165, no. 1, pp. 30–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Miyamoto, H. Ohtaki, K. Dohi et al., “Edaravone increased regional cerebral blood flow after TBI,” Acta Neurochirurgica. In press.
  34. J. I. Oyama, S. Satoh, N. Suematsu et al., “Scavenging free radicals improves endothelial dysfunction in human coronary arteries in vivo,” Heart and Vessels, vol. 25, no. 5, pp. 379–385, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Dohi, K. Satoh, T. Nakamachi et al., “Novel free radical monitoring in patients with neurological emergency diseases,” Acta Neurochirurgica, vol. 106, pp. 315–319, 2010. View at Scopus
  36. M. Bains and E. D. Hall, “Antioxidant therapies in traumatic brain and spinal cord injury,” Biochimica et Biophysica Acta, vol. 1822, pp. 675–684, 2012.
  37. W. Lo, T. Bravo, V. Jadhav, E. Titova, J. H. Zhang, and J. Tang, “NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury,” Neuroscience Letters, vol. 414, no. 3, pp. 228–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Dawson, K. R. Lees, C. J. Weir et al., “Baseline serum urate and 90-day functional outcomes following acute ischemic stroke,” Cerebrovascular Diseases, vol. 28, no. 2, pp. 202–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. W. P. M. Hukkelhoven, E. W. Steyerberg, E. Farace, J. D. F. Habbema, L. F. Marshall, and A. I. R. Maas, “Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials,” Journal of Neurosurgery, vol. 97, no. 3, pp. 549–557, 2002. View at Scopus
  40. T. Nakase, S. Yoshioka, and A. Suzuki, “Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke,” BMC Neurology, vol. 11, article 39, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Utsumi, K. I. Yamada, K. Ichikawa et al., “Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 5, pp. 1463–1468, 2006. View at Publisher · View at Google Scholar · View at Scopus